// Research Stack — QSC Peptides

Bulking Research StackTestosterone + Nandrolone (DECA) + Dianabol — QSC Peptides Research Reference

The classic mass-building research combination: Testosterone Enanthate (full AR agonist + aromatization baseline), Nandrolone Decanoate (high anabolic:androgenic selectivity + PR activity + collagen synthesis), and Dianabol (rapid-onset oral AAS + methylestradiol estrogenicity). Three complementary pharmacological profiles targeting maximized anabolic signaling.

Shop All QSC Steroids →
QSC Peptides ≥99% Purity Verified COA Every Order Free USA USPS/FedEx US Domestic Stock 8 Warehouse Regions
// Stack Compounds

Compounds in This Research Stack

Foundation
Test Enanthate 250mg/mL | 10-Vial
Full AR agonist · Aromatizes to E2 · ~7 day t½

QSC Peptides · 100:100 baseline

≥99% Pure · COA
19-Nor
Nandrolone DECA 200mg/mL | 10-Vial
125:37 · AR + PR · Collagen synthesis

QSC Peptides · Low androgenicity

≥99% Pure · COA
Oral Kickstart
Dianabol 50mg Tablets | 100-Count
Fast onset · 210:60 · Aromatizes to MeE2

QSC Peptides · C17α oral

≥99% Pure · COA
PCT
Clomiphene 50mg | 100-Count
SERM · Post-protocol HPTA restoration

QSC Peptides

≥99% Pure · COA
// Stack Analysis

Pharmacological Rationale

CompoundReceptor TargetsA:A RatioAromatizesDuration
Test EnanthateAR (full agonist)100:100→ E2Full protocol
Nandrolone DECAAR + PR125:37Minimal → E1Full protocol
Dianabol 50mgAR + ER (via MeE2)210:60→ MeE2Weeks 1–6 (oral kickstart)
Clomid (PCT)ER antagonist (hypo)N/AN/APost-protocol

Why These Three Compounds Are Complementary

Testosterone Enanthate provides the foundational AR activation — the endogenous reference compound at 100:100. Its aromatization to E2 provides the estrogenic component (IGF-1 upregulation, bone density, CNS effects) while establishing the AR baseline against which the other compounds are studied.

Nandrolone Decanoate (DECA) adds a 19-nor AR agonist with higher anabolic selectivity (125:37) and unique progestin receptor activity. The 5α-reduction to inactive DHN means nandrolone doesn't amplify androgenicity in sensitive tissues — providing additive anabolic signaling with minimal androgenic overlap. Additionally, nandrolone increases synovial fluid production and collagen type I/III synthesis — tissue effects not produced by testosterone alone.

Dianabol as an oral compound provides rapid-onset AR activation in the first weeks of research (before injectable compounds reach full steady-state) and adds the unique pharmacology of 17α-methylestradiol — a more potent ER agonist than native E2, providing a third estrogenic research variable.

// FAQ

Stack Research FAQ

Injectable long-ester AAS (Testosterone, Nandrolone) require weeks to reach steady-state blood levels. An oral compound like Dianabol has a ~4-hour half-life and reaches peak concentrations within days, providing AR activation while injectables build up — a pharmacokinetically complementary 'kickstart' research design.
Testosterone is the endogenous androgen, the 100:100 reference, and provides foundational AR activation plus E2 production via aromatization. In combined AAS research protocols, testosterone maintains the hormonal baseline against which other compounds' additive effects are measured.
Nandrolone adds: additional anabolic receptor activation (125:37 selectivity), PR co-agonism (distinct from testosterone's pure AR activity), minimal aromatization, and unique tissue effects including collagen synthesis and joint fluid production — all distinct from testosterone's pharmacology.
// Related

Related Research Pages

Testosterone
Reference Compound
View reference →
Nandrolone
DECA + NPP
View reference →
Dianabol
Oral AAS
View reference →
PCT Compounds
HPTA Restoration
View reference →
Cutting Stack
Research Stack
View reference →

QSC Network